Perianal Crohn’s Disease



Crohn’s disease has been associated with perianal fistulation since the condition was first recognized. The pathophysiology of anal involvement is initiated by a penetrating ulcer which can progress to form a fistula to the perineum, vagina, or scrotum. Perianal Crohn’s disease (PCD) can also produce an anal stricture, typically in the upper anal canal [1]. Thus the characteristic lesions of perianal Crohn’s disease are ulceration, fistula/abscess, and stricture (Table 22.1).


Advancement Flap Infliximab Therapy Perianal Fistula Infliximab Infusion Perianal Sepsis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hughes LE. Clinical classification of perianal Crohn’s disease. Dis Colon Rectum. 1992;35:928–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Keighley MRB, Allan RN. Current status and influence of operation on perianal Crohn’s disease. Colorectal Dis. 1986;1:104–7.CrossRefGoogle Scholar
  3. 3.
    Schwartz DA, Loftus Jr EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Duffy LF, Daum F, Fisher SE, Selman J, Vishnubhakat SM, Aiges HW, Markowitz JF, Silverberg M. Peripheral neuropathy in Crohn’s disease patients treated with metronidazole. Gastroenterology. 1985;88(3):681–4.PubMedGoogle Scholar
  5. 5.
    Hughes LE, Donaldson DR, Williams JG, Taylor BA, Young HL. Local depot methylprednisolone injection for painful anal Crohn’s disease. Gastroenterology. 1988;94:709–11.PubMedGoogle Scholar
  6. 6.
    Schrodt BJ, Callen JP. Metastatic Crohn’s disease presenting as chronic perivulvar and perirectal ulcerations in an adolescent patient. Pediatrics. 1999;103(2):500–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Eradi B, Sandhu BK, Spray C, Cusick E. Highly destructive perianal Crohn disease. J Pediatr Gastroenterol Nutr. 2005;41(5):667–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Williams JG, Rothenberger DA, Nemer FD, Goldberg SM. Fistula-in-ano in Crohn’s disease: results of aggressive surgical treatment. Dis Colon Rectum. 1991;34:378–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Williams JG, MacLeod CA, Rothenberger DA, Goldberg SM. Seton treatment of high anal fistulae. Br J Surg. 1991;78:1159–61.PubMedCrossRefGoogle Scholar
  10. 10.
    Taxonera C, Schwartz DA, García-Olmo D. Emerging treatments for complex perianal fistula in Crohn’s disease. World J Gastroenterol. 2009;15(34):4263–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg. 2004;91:476–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Thornton M, Solomon MJ. Long-term indwelling seton for complex anal fistulas in Crohn’s disease. Dis Colon Rectum. 2005;48:459–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Schwandner O, Stadler F, Dietl O, Wirsching RP, Fuerst A. Initial experience on efficacy in closure of cryptoglandular and Crohn’s transsphincteric fistulas by the use of the anal fistula plug. Int J Colorectal Dis. 2008;23:319–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Lindsey I, Smilgin-Humphreys MM, Cunningham C, Mortensen NJ, George BD. A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula. Dis Colon Rectum. 2002;45:1608–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Mizrahi N, Wexner SD, Zmora O, Da Silva G, Efron J, Weiss EG, Vernava III AM, Nogueras JJ. Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum. 2002;45:1616–21.PubMedCrossRefGoogle Scholar
  16. 16.
    Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350(9):876–85.PubMedCrossRefGoogle Scholar
  17. 17.
    Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med. 1999;340(18):1398–405.PubMedCrossRefGoogle Scholar
  18. 18.
    van Bodegraven AA, Sloots CEJ, Felt-Bersma RJF, Meuwissen SGM. Endosonographic evidence of persistence of Crohn’s disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum. 2002;45:39–46.PubMedCrossRefGoogle Scholar
  19. 19.
    Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D’Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol. 2003;98(2):332–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Bell SJ, Halligan S, Windsor AC, Williams AB, Wiesel P, Kamm MA. Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2003;17(3):387–93.PubMedCrossRefGoogle Scholar
  21. 21.
    Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease. Gastroenterology. 2005;128(4):862–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9(2):98–103.PubMedCrossRefGoogle Scholar
  23. 23.
    Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn’s disease: results of combined surgical and infliximab treatment. Dis Colon Rectum. 2006;49:1837–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP. Does infliximab infusion impact results of operative treatment for Crohn’s perianal fistulas? Dis Colon Rectum. 2007;50(11):1754–60.PubMedCrossRefGoogle Scholar
  25. 25.
    Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D. Infliximab in the surgical management of complex fistulating anal Crohn’s disease. Colorectal Dis. 2004;7(2):164–8.CrossRefGoogle Scholar
  26. 26.
    Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME. Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum. 2007;50(12):2067–74.PubMedCrossRefGoogle Scholar
  27. 27.
    Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg. 2000;24:1258–63.PubMedCrossRefGoogle Scholar
  28. 28.
    Yamamoto T, Allan RN, Keighley MRB. Audit of single-stage proctocolectomy for Crohn’s disease: postoperative complications and recurrence. Dis Colon Rectum. 2000;43:249–56.PubMedCrossRefGoogle Scholar
  29. 29.
    Brough WA, Schofield PF. The value of the rectus abdominis myocutaneous flap in the treatment of complex perineal fistula. Dis Colon Rectum. 1991;34:148–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Department of Colorectal SurgeryRoyal Preston HospitalFulwood, Preston, LancashireUK

Personalised recommendations